Both in Pharmaceuticals
Galectin Therapeutics vs Benitec Biopharma
Over the past year GALT returned −37.3% and BNTC returned −45.0%; their daily moves had a correlation of 0.20.
GALT −37.3% BNTC −45.0%Growth of $1, one year, split-adjusted
| Metric | GALT | BNTC |
|---|---|---|
| Price | $3.20 | $8.63 |
| Market cap | $322.7M | $301.1M |
| Today | +0.31% | −0.23% |
| 1 month | −17.9% | −10.0% |
| 6 months | +35.0% | −31.6% |
| Year to date | −23.1% | −35.9% |
| 1 year | −37.6% | −45.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | -$19.8M | $180.0M |
| Dividend yield | — | — |
| Volatility (60d) | 63.9% | 58.1% |
| Short % of float | 13.8% | 9.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).